Cross-sectional study to assess the effectiveness of the patients’ alert card to inform on the risk of differentiation syndrome in AML patients treated with TIBSOVO® (Ivosidenib) (IMPACTA)

Data sources

• Data source(s), other:
  Structured, self-administered questionnaire comprising closed-ended questions or statements with multiple response choices will be used to collect the survey data. A user testing evaluation will be conducted prior to the master study.
• Data sources (types):
  Patient surveys

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No